Last reviewed · How we verify

NCT06180317

The Effect of Virtual Reality on Anxiety and Pain During Endometrial Biopsy

Completed NA Last updated 9 January 2025
What this trial tests

NA trial testing Virtual reality in Endometrial Biopsy in 80 participants. Completed in 28 November 2024.

Timeline
1 March 2024
Primary endpoint
25 November 2024
28 November 2024

Quick facts

Lead sponsorKırklareli University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment80
Start date1 March 2024
Primary completion25 November 2024
Estimated completion28 November 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kırklareli University

Who can join

Adults 18 to 85, female only, with Endometrial Biopsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to reduce the anxiety and pain felt during endometrial biopsy procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual reality

Trials testing the same drug.

Other recruiting trials for Endometrial Biopsy

Currently open trials in the same condition.

Other Kırklareli University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06180317.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing